Weight loss drugs have been pitted against each other in a first of its kind head-to-head trial. Mounjaro and Wegovy were put ...

Landmark research suggests the appetite-suppressing jabs which mimic a hormone that makes us feel full also significantly cut ...

In a 72-week trial, people taking Zepbound lost 50 pounds on average, compared with about 33 pounds for people taking Wegovy.

Eli Lilly’s obesity drug Zepbound led to nearly 50 percent more weight loss than Novo Nordisk’s Wegovy in the first direct ...

True or False: Pooled trial data showed that rheumatoid arthritis patients taking tofacitinib (Xeljanz) were less likely to gain weight. The FDA and CDC jointly recommended to pause use of the ...

Weight-loss jab Mounjaro helps people shed significantly more weight than rival Wegovy, new research suggests.

One weight loss injection has been branded more effective than another, after scientists carry out the first ever ...

A new study shows that people Zepbound lost about 50% more weight than those using Wegovy. It was the first head-to-head ...

The head-to-head examination of these weight loss drugs provides doctors with 'robust' data on their effectiveness.

Newer medications, such as Mounjaro and Wegovy, exhibit both more total weight lost and faster weight regain than older ...

Those who take tirzepatide, the drug sold as Zepbound and Mounjaro, could lose more weight than those who take semaglutide, ...

(Note: The Hers platform offers access to Wegovy, if prescribed, for people 18 and older, at 50 percent off the retail price.) It’s a powerful tool for weight loss, but it’s not a magic ...